Multi-omic serum biomarkers for prognosis of disease progression in prostate cancer

BACKGROUND: Predicting the clinical course of prostate cancer is challenging due to the wide biological spectrum of the disease. The objective of our study was to identify prostate cancer prognostic markers in patients ‘sera using a multi-omics discovery platform. METHODS: Pre-surgical serum samples...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiebish, Michael A., Cullen, Jennifer, Mishra, Prachi, Ali, Amina, Milliman, Eric, Rodrigues, Leonardo O., Chen, Emily Y., Tolstikov, Vladimir, Zhang, Lixia, Panagopoulos, Kiki, Shah, Punit, Chen, Yongmei, Petrovics, Gyorgy, Rosner, Inger L., Sesterhenn, Isabell A., McLeod, David G., Granger, Elder, Sarangarajan, Rangaprasad, Akmaev, Viatcheslav, Srinivasan, Alagarsamy, Srivastava, Shiv, Narain, Niven R., Dobi, Albert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945688/
https://www.ncbi.nlm.nih.gov/pubmed/31910880
http://dx.doi.org/10.1186/s12967-019-02185-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945688/
https://www.ncbi.nlm.nih.gov/pubmed/31910880
http://dx.doi.org/10.1186/s12967-019-02185-y

Ejemplares similares